DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,801,206 | +5.6% | 7,260 | +2.1% | 0.21% | +10.4% |
| Q2 2023 | $1,706,400 | -4.8% | 7,110 | 0.0% | 0.19% | -11.5% |
| Q1 2023 | $1,792,004 | -6.3% | 7,110 | -1.3% | 0.22% | -9.2% |
| Q4 2022 | $1,912,617 | +3.2% | 7,206 | +0.4% | 0.24% | -2.8% |
| Q3 2022 | $1,853,000 | +2.8% | 7,175 | +0.9% | 0.25% | +8.8% |
| Q2 2022 | $1,803,000 | -13.6% | 7,110 | 0.0% | 0.23% | +3.2% |
| Q1 2022 | $2,086,000 | -10.8% | 7,110 | 0.0% | 0.22% | -8.3% |
| Q4 2021 | $2,339,000 | +8.0% | 7,110 | -0.1% | 0.24% | -2.8% |
| Q3 2021 | $2,166,000 | +13.5% | 7,115 | 0.0% | 0.25% | +38.8% |
| Q2 2021 | $1,909,000 | +19.2% | 7,115 | 0.0% | 0.18% | +10.6% |
| Q1 2021 | $1,601,000 | +2.3% | 7,115 | +1.0% | 0.16% | -8.0% |
| Q4 2020 | $1,565,000 | +3.0% | 7,046 | -0.2% | 0.18% | -6.9% |
| Q3 2020 | $1,520,000 | +22.0% | 7,059 | +0.2% | 0.19% | +11.9% |
| Q2 2020 | $1,246,000 | +27.8% | 7,046 | 0.0% | 0.17% | +5.7% |
| Q1 2020 | $975,000 | -9.8% | 7,046 | 0.0% | 0.16% | +29.3% |
| Q4 2019 | $1,081,000 | +5.5% | 7,046 | -0.7% | 0.12% | -3.1% |
| Q3 2019 | $1,025,000 | -11.5% | 7,099 | -12.3% | 0.13% | -13.0% |
| Q2 2019 | $1,158,000 | +8.3% | 8,099 | 0.0% | 0.15% | +3.5% |
| Q1 2019 | $1,069,000 | +28.0% | 8,099 | 0.0% | 0.14% | +12.8% |
| Q4 2018 | $835,000 | -5.1% | 8,099 | 0.0% | 0.12% | +14.7% |
| Q3 2018 | $880,000 | +10.1% | 8,099 | 0.0% | 0.11% | +1.9% |
| Q2 2018 | $799,000 | +0.8% | 8,099 | 0.0% | 0.11% | +0.9% |
| Q1 2018 | $793,000 | -1.6% | 8,099 | 0.0% | 0.11% | +3.9% |
| Q4 2017 | $806,000 | +27.9% | 8,099 | +10.2% | 0.10% | +20.0% |
| Q3 2017 | $630,000 | +1.6% | 7,349 | 0.0% | 0.08% | 0.0% |
| Q2 2017 | $620,000 | -1.4% | 7,349 | 0.0% | 0.08% | -4.5% |
| Q1 2017 | $629,000 | +8.4% | 7,349 | -1.4% | 0.09% | +1.1% |
| Q4 2016 | $580,000 | +14.6% | 7,455 | +15.5% | 0.09% | +12.8% |
| Q3 2016 | $506,000 | -22.4% | 6,455 | 0.0% | 0.08% | -24.3% |
| Q2 2016 | $652,000 | +6.5% | 6,455 | 0.0% | 0.10% | +8.4% |
| Q1 2016 | $612,000 | +2.0% | 6,455 | 0.0% | 0.10% | +5.6% |
| Q4 2015 | $600,000 | +6.4% | 6,455 | -2.4% | 0.09% | +4.7% |
| Q3 2015 | $564,000 | -39.9% | 6,617 | -39.7% | 0.09% | -37.2% |
| Q2 2015 | $939,000 | +2.3% | 10,976 | +1.5% | 0.14% | +5.4% |
| Q1 2015 | $918,000 | -1.0% | 10,816 | 0.0% | 0.13% | -4.4% |
| Q4 2014 | $927,000 | +12.8% | 10,816 | 0.0% | 0.14% | +12.4% |
| Q3 2014 | $822,000 | -3.5% | 10,816 | 0.0% | 0.12% | -3.2% |
| Q2 2014 | $852,000 | +5.1% | 10,816 | 0.0% | 0.12% | -2.3% |
| Q1 2014 | $811,000 | -1.9% | 10,816 | +0.9% | 0.13% | -2.3% |
| Q4 2013 | $827,000 | +11.3% | 10,716 | 0.0% | 0.13% | +0.8% |
| Q3 2013 | $743,000 | -7.0% | 10,716 | -15.1% | 0.13% | -8.5% |
| Q2 2013 | $799,000 | – | 12,618 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |